Visit Noom Med Best With No Subscription: TrimRx month-to-month options without auto-renew lock-in
If your employer's plan excludes anti-obesity medications entirely (common in self-insured plans), your options are: the cash-pay manufacturer programs described above, asking your HR department whether the exclusion can be reconsidered (especially if your employer is large enough to modify the plan), or using the medication under a different indication (for example, Ozempic for type 2 diabetes, if applicable)
These options range from skin-tightening technologies to surgical fat grafting and are particularly beneficial for those with significant volume loss, poor skin elasticity, or a preference for more permanent solutions
Zepbound is approved by the FDA as a weight loss management treatment for people with obesity or those who are overweight with at least one weight-related condition such as high blood pressure
A pertinent consideration with filler products is the risk of patients appearing overcorrected if they gain weight rather than losing it
GLP-1 receptor activation appears to release the accelerator (reducing inflammatory effector cells) while strengthening the brake (enhancing regulatory cells)